GP
GSK icon

Guardian Partners’s GSK GSK Stock Holding History

Guardian Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.1K Buy
+440
New +$23.3K ﹤0.01% 311

Other funds holding GSK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Guardian Partners's GSK Position: Q2 2026 in Review

Guardian Partners opened a new position in GSK (GSK) in Q2 2026: 440 shares worth $23.1K. The stake represents ﹤0.01% of the portfolio and ranks #311 among its holdings.

403 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Guardian Partners held 440 shares of GSK worth $23.1K as of Q2 2026.
  • GSK was a new Guardian Partners position in Q2 2026.
  • GSK made up ﹤0.01% of Guardian Partners's portfolio in Q2 2026, its #311 holding.
  • 403 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.